Fig. 2From: Tanshinone IIA prevents platelet activation and down-regulates CD36 and MKK4/JNK2 signaling pathwayIL-6–PMVs activate platelets in a CD36-dependent manner. Percentage of PAC-1 positive platelets, after incubation of CD36-positive platelets a or CD36-deficient platelets b with IL-6–PMVs for 30 min. Data are means ± SD from 3 separate experiments. * P < 0.05 compared with untreated controlBack to article page